Navigation Links
Hepatic function testing can assist in treatment planning for liver cancer patients
Date:2/8/2013

Orlando, Fla., February 8, 2013 Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during radiation therapy, provides vital information that could guide more customized treatment plans and reduce risks of liver injury, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North American (RSNA).

This study included 14 patients who had unresectable intrahepatic cancers and were treated with 3-D conformal radiation therapy (3-D CRT), intensity modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) at a median dose of 52 Gy. Patients underwent HIDA SPECT scanning prior to radiation therapy, after delivery of 50 to 60 percent of the planned doses and one month after completion of radiation therapy. In addition, indocyanine green tests, a measure of overall liver function, were performed +/- one day of each SPECT scan. The 27 dynamic HIDA SPECT volumes were acquired over a 60-minute period after the administration of 10 mCi 99mTc-labeled HIDA on a SPECT/CT scanner.

Measuring the regional liver function prior to radiation therapy allows assessment of the precondition of the patient's liver function. Evaluating the change of the regional liver function during the mid-course of radiation therapy indicates the response of the individual patient's liver to radiation doses. Combining the planned radiation doses with the regional liver function assessment and re-assessment, investigators developed a model to predict the regional liver function post-radiation therapy. This information is vital to providing patients with the highest radiation doses for better tumor control, while minimizing the risk for each patient.

"Through this assessment method, patients could potentially receive more treatment doses tailored to meet their needs, based on their liver function," said Hesheng Wang, PhD, the lead study author and a postdoctoral fellow in radiation oncology at the University of Michigan in Ann Arbor, Mich. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing."


'/>"/>

Contact: Michelle Kirkwood
press@astro.org
703-286-1600
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. New technology may help doctors monitor concussions, aging, and neurological function
2. Does the functionality of your small finger determine your ability to master the violin?
3. Easy On Hold Reviews Latest Small Business Phone Systems for Music On Hold Ease and Functionality
4. Popular Medical Tourism Portal, myMEDholiday.com, Expands Its Functionality by Adding RSS Feeds
5. The Elator Announces it's Recognition from The Sinclair Institute for its Penile Support Device for Men Suffering from Erectile Dysfunction
6. Prostate cancer study tracks long-term urinary, sexual and bowel function side effects
7. Erectile Dysfunction May Signal Hidden Heart Disease
8. Erectile dysfunction drug also helps men ejaculate and orgasm
9. Studying possible ways of solving the crisis in the care function
10. Immunology research sheds new light on cell function, response
11. Noise protection - multifunctional and aesthetical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
(Date:12/5/2016)... ... ... BSI and Brenntag Canada have been appointed by Chr. Hansen as their ... fruits and beverage colorants effective November 1, 2016. , “The ... product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing Chr. Hansen will ...
(Date:12/5/2016)... ... December 05, 2016 , ... Sideline Products is a Southern York ... both the smaller rider and the horse. Smaller saddles can pinch and irritate the ... to fit over a properly fitted western saddle so it does not impact the ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Life Will Never Be ... supportive family and friends. “Life Will Never Be The Same” is the creation of ... in writing children's books and holds a degree in Christian religion and philosophy from ...
(Date:12/5/2016)... ... ... MBA has joined the Retina Group of New York (RGONY) specializing in uveitis ... MD and has been providing tertiary medical and surgical retinal care on Long Island for ... her peers. Growing up in a family of doctors, Dr. Shah emulated the role ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016  New research by the CVS Health ... the U.S. Department of Health and Human Services, ... Response (ASPR), published online today in JAMA ... encourage patients with chronic conditions to refill medications ... also affirms that public-private partnerships can facilitate timely ...
(Date:12/5/2016)... of Spectrum Science Communications , announced today that Jonathan ... consecutive years of high double digit growth in fee revenues. ... management of the firm that Seng founded in 1996. Earlier in ... the Year and was selected among the Best Places to Work. ... ...
(Date:12/5/2016)...  Seno Medical Instruments, Inc., the company pioneering the ... improve the process of diagnosing breast cancer, today announced ... post-market surveillance and clinical follow-up study at the 2016 ... place from December 6-10, 2016 at the Henry B. ... . Seno Medical Instruments will present ...
Breaking Medicine Technology: